Literature DB >> 16671998

Spontaneous senescence in the MDA-MB-231 cell line.

A Cukusić1, M Ivanković, N Skrobot, M Ferenac, I Gotić, M Matijasić, D Polancec, I Rubelj.   

Abstract

Normal human somatic cells have a limited division potential when they grow in vitro. It is believed that shortening of telomeres, specialized structures at the ends of chromosomes, controls cell growth. When one telomere achieves a critical minimal length, the cell cycle control mechanism recognizes it as DNA damage and causes the cell's exit from the cycle in G1-phase. Because it is not possible to extend telomeres in normal cells, this non-dividing state is prolonged indefinitely, and is known as cellular senescence. The immortal cell line MDA-MB-231 has active telomerase, which prevents telomere shortening and allows cells' permanent divisions. However, there is a fraction of cells that do not divide over several days in culture as documented for some other tumour cell lines. Combination of methods has made it possible to isolate these non-growing cells and compare them with the fraction of fast-growing cells from the same culture. Although the non-growing fraction contains a significant percentage of typical senescent cells, both fractions have equal telomerase activity and telomere length. In this paper we discuss possible mechanisms that cause the appearance of this non-growing fraction of cells in cultures of MDA-MB-231, which indicate stress and genome instability rather than variation in telomerase activity or telomere shortening to affect individual cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16671998      PMCID: PMC6496020          DOI: 10.1111/j.1365-2184.2006.00383.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  35 in total

Review 1.  Telomere maintenance and cancer -- look, no telomerase.

Authors:  Axel A Neumann; Roger R Reddel
Journal:  Nat Rev Cancer       Date:  2002-11       Impact factor: 60.716

2.  A single-stage mechanism controls replicative senescence through Sudden Senescence Syndrome.

Authors:  Ivica Rubelj; Miljenko Huzak; Branko Brdar; Olivia M Pereira-Smith
Journal:  Biogerontology       Date:  2002       Impact factor: 4.277

Review 3.  Molecular changes with in vitro cellular senescence.

Authors:  V J Cristofalo; R J Pignolo; M O Rotenberg
Journal:  Ann N Y Acad Sci       Date:  1992-11-21       Impact factor: 5.691

4.  Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening.

Authors:  V L Makarov; Y Hirose; J P Langmore
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

5.  Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions.

Authors:  R D Ramirez; C P Morales; B S Herbert; J M Rohde; C Passons; J W Shay; W E Wright
Journal:  Genes Dev       Date:  2001-02-15       Impact factor: 11.361

Review 6.  Protection of mammalian telomeres.

Authors:  Titia de Lange
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

Review 7.  Cancer and aging: the importance of telomeres in genome maintenance.

Authors:  Francis Rodier; Sahn-Ho Kim; Tarlochan Nijjar; Paul Yaswen; Judith Campisi
Journal:  Int J Biochem Cell Biol       Date:  2005-01-04       Impact factor: 5.085

8.  Early-senescing human skin fibroblasts do not demonstrate accelerated telomere shortening.

Authors:  Marina Ferenac; Denis Polancec; Miljenko Huzak; Olivia M Pereira-Smith; Ivica Rubelj
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-07       Impact factor: 6.053

9.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

Review 10.  Replicative senescence: a critical review.

Authors:  Vincent J Cristofalo; Antonello Lorenzini; R G Allen; Claudio Torres; Maria Tresini
Journal:  Mech Ageing Dev       Date:  2004 Oct-Nov       Impact factor: 5.432

View more
  2 in total

1.  Tebrophen--an old polyphenol drug with anticancer potential.

Authors:  Ivica Rubelj; Višnja Stepanić; Dubravko Jelić; Nikolina Škrobot Vidaček; Andrea Ćukušić Kalajžić; Milena Ivanković; Krunoslav Nujić; Mario Matijašić; Donatella Verbanac
Journal:  Molecules       Date:  2012-06-28       Impact factor: 4.411

2.  Deciphering the Molecular Mechanism of Spontaneous Senescence in Primary Epithelial Ovarian Cancer Cells.

Authors:  Martyna Pakuła; Ewa Mały; Paweł Uruski; Anna Witucka; Małgorzata Bogucka; Natalia Jaroszewska; Nicoletta Makowska; Arkadiusz Niklas; Rafał Moszyński; Stefan Sajdak; Andrzej Tykarski; Justyna Mikuła-Pietrasik; Krzysztof Książek
Journal:  Cancers (Basel)       Date:  2020-01-27       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.